Avalon GloboCare Corp. is a biotechnology company in the clinical development stage, specializing in CellTech research with a focus on advancing and empowering innovative immune effector cell therapy and exosome technology. Additionally, Avalon offers strategic advisory and outsourcing services to support and enhance the growth, development, and competitiveness of its clients in the healthcare and CellTech industry markets.